“IN-VITRO EFFICACY OF PIPERACILLIN SULBACTAM AGAINST MULTIDRUG-RESISTANT PSEUDOMONAS AERUGINOSA: A COMPARATIVE STUDY WITH PIPERACILLIN TAZOBACTAM AND CEFOPERAZONE SULBACTAM”. 2026. Frontier in Medical and Health Research 4 (3): 4971-77. https://fmhr.net/index.php/fmhr/article/view/3904.